LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/RTI Launches Fortilink-TS and -L IBF Systems With TETRAfuse
Spine

RTI Launches Fortilink-TS and -L IBF Systems With TETRAfuse

June 26, 2018 2 min read Premium comments

Advertisement

RTI Launches Fortilink-TS and -L IBF Systems With TETRAfuse
Fortilink-TS IBF System / Courtesy of RTI Surgical
#spineimplantsSecondary#rtisurgical#fortilink

RTI Surgical, Inc., based in Alachua, Florida, has announced the launch of a new platform of 3D printed, polymer based interbody fusion devices, Fortilink-TS and -L IBF Systems.

According to the company, “…The Fortilink-TS and -L Systems are intended for use in lumbar interbody fusion procedures at one or two adjoining levels in patients with degenerative disc disease.”

“TETRAfuse 3D Technology is the first 3D printed polymer-based interbody fusion device to incorporate a nano-roughened surface that has demonstrated, in a pre-clinical study, more notable trabecular bone ingrowth compared to PEEK and titanium-coated PEEK.”

“The Fortilink-L IBF System is intended for a lateral transpsoas approach to the lumbar spine, also known as lateral lumbar interbody fusion (LLIF) surgeries. The Fortilink-TS System is intended for traditional posterior approaches known as transforaminal lumbar interbody fusion (TLIF) or bilateral posterior lumbar interbody fusion (PLIF) surgeries. TETRAfuse 3D Technology features a nano-rough surface with antibacterial characteristics and is designed to participate in fusion without compromising mechanical integrity or radiographic visibility.”

John O’Toole, M.D., M.S., Professor of Neurosurgery at Rush University Medical Center in Chicago, Illinois, and one of the first surgeons to implant the Fortilink-TS device, added, “The introduction of TETRAfuse 3D Technology revolutionizes the interbody device market by combining a favorable modulus of elasticity, optimal imaging characteristics and a surface design promoting vigorous bone ingrowth. I believe TETRAfuse 3D Technology meets all the criteria for an interbody through enhanced biology, biomechanics and ease of use to help improve outcomes for patients.”

Joseph O’Brien, M.D., M.P.H., founder of the Washington Spine & Scoliosis Institute at Ortho Bethesda in Bethesda, Maryland, and one of the first surgeons to implant the Fortilink-L device, told OTW, “In my experience, PEEK material is hydrophobic whereas TETRAfuse 3D Technology has a nano scale rough surface architecture and is hydrophilic. This creates a more favorable environment for new bone growth, while maintaining the radiolucency of PEEK to monitor fusion status.”

“I know many surgeons, like me, looking for interbody implant solutions that can be used with different types of bone graft substitute without compromising outcomes. With superior implant technology, like TETRAfuse 3D Technology, I can select a more cost-effective bone graft substitute and still expect as good or better results more quickly.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy